The CAFFE study aims to optimize AF management to reduce frailty and improve outcomes in older patients with persistent AF, but no specific results are reported yet.
Do therapeutic options for atrial fibrillation exert a protective effect against frailty development and improve functional outcomes, HRQL, and cognitive performance in older patients with persistent AF?
The CAFFE study is designed to investigate whether therapeutic options for persistent atrial fibrillation can reduce frailty and improve functional and cognitive outcomes in older patients.
Absolute Event Rate: 0% vs 0%
The CAFFE study seeks to provide valuable insights to optimize AF management strategies in order to reduce frailty and to improve functional outcomes, HRQL, and cognitive performance of older patients with the persistent forms of the arrhythmia, thereby addressing some knowledge gaps of current evidence. The CAFFE Study, as a PRIN (Progetti di Ricerca di Rilevante Interesse Nazionale - 2022L9NPKH), is financed by the Italian Ministry of the University and the Research, and by the European Union (NextGenerationEU).
Berni et al. (Wed,) reported a other. The CAFFE study aims to optimize AF management to reduce frailty and improve outcomes in older patients with persistent AF, but no specific results are reported yet.